Physician profile
Robert E Kent
NPI 1730407917
$496.15
in general payments reported to CMS, 2019-2025
9 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.98 · 2021: $152 · 2024: $43.56 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $243.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $152.37 | 2021 | |
| Abbvie INC. | $125.00 | 2025 | |
| Medtronic, INC. | $90.67 | 2024-2025 | Linq II, Intellis Adaptivestim |
| Si-Bone, INC. | $36.36 | 2019 | |
| Emd Serono, INC. | $28.13 | 2024 | |
| Abbott Laboratories | $23.69 | 2019 | |
| Zyla Life Sciences, INC. | $14.30 | 2019 | |
| Avanir Pharmaceuticals, INC. | $13.98 | 2019 | |
| Boston Scientific Corporation | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Kent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.